Skip to content
Sunday, May 11, 2025
  • Twitter
  • Facebook
  • YouTube
  • Discord

ContraReport

  • Blog
  • Science
  • Epigenetics
  • Microbiota
  • Neuroscience
  • Nutrition
  • COVID-19
  • ContraRisks

Year: 2022

  • Home
  • 2022
  • Page 4

Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial

  • January 28, 2022
  • 0

“Vitamin D supplementation for five years, with or without omega 3 fatty acids, reduced autoimmune disease by 22%, while omega 3 fatty acid supplementation with or without vitamin D reduced […]

Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis – facts and hypotheses (2021) 

  • January 27, 2022
  • 0

“Here, we summarize the important data on vitamin D, including polymorphisms in genes related to vitamin D metabolism, EBV and ERV, in the pathogenesis of MS and create hypotheses regarding […]

Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and AE after HPV Vaccination?

  • January 21, 2022
  • 0

“We highlight the role of three mechanisms—autoimmunity, neuroinflammation, and small fiber neuropathy—in the pathogenesis of the disease [fibromyalgia].”

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

  • January 14, 2022
  • 0

“The team analyzed serum samples taken biennially by the military and determined the soldiers’ EBV status at time of first sample and the relationship between EBV infection and MS onset […]

COVID-19 Literature V

  • January 3, 2022
  • 0

literature published in 2022-2025 Updated February 22, 2025

Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers

  • January 3, 2022
  • 0

“…these findings further explain why some individuals may be able to control HIV-1 viral loads without ART.”

Posts navigation

Newer posts
Copyright © 2025 ContraReport Theme: Present News By Adore Themes.